Phase 1 study of DS-3201b to assess the effects of itraconazole and fluconazole on the pharmacokinetics of single oral administration of DS-3201b tablets in healthy Japanese subjects
Phase of Trial: Phase I
Latest Information Update: 04 Oct 2018
At a glance
- Drugs DS 3201 (Primary) ; Fluconazole; Itraconazole
- Indications Acute myeloid leukaemia; Non-Hodgkin's lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Pharmacokinetics
- Sponsors Daiichi Sankyo Company
- 26 Sep 2018 Status changed from active, no longer recruiting to completed.
- 27 Apr 2018 Status changed from not yet recruiting to active, no longer recruiting.
- 21 Mar 2018 New trial record